New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future.
about
Progress in pediatrics in 2011. Choices in endocrinology, gastroenterology, hemato-oncology, infectious diseases, otolaryngology, pharmacotherapy and respiratory tract illnesses.The future is now: chimeric antigen receptors as new targeted therapies for childhood cancerTargeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor.Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo.Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children.
P2860
New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
New advances in leukaemia immu ...... spectives for the near future.
@en
New advances in leukaemia immu ...... c Artificial Antigen Receptors
@nl
type
label
New advances in leukaemia immu ...... spectives for the near future.
@en
New advances in leukaemia immu ...... c Artificial Antigen Receptors
@nl
prefLabel
New advances in leukaemia immu ...... spectives for the near future.
@en
New advances in leukaemia immu ...... c Artificial Antigen Receptors
@nl
P2093
P2860
P921
P356
P1476
New advances in leukaemia immu ...... spectives for the near future.
@en
P2093
Andrea Biondi
Elisabetta Cribioli
Ettore Biagi
Greta Maria Paola Giordano Attianese
Irene Pizzitola
Sarah Tettamanti
Virna Marin
P2860
P2888
P356
10.1186/1824-7288-37-46
P5008
P577
2011-09-22T00:00:00Z
P5875
P6179
1024097182